Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells.
about
A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acidsEGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in miceProgress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseasesStructural characterization of cationic lipid-tRNA complexes.Investigating the effects of block versus statistical glycopolycations containing primary and tertiary amines for plasmid DNA delivery.DNA release dynamics from reducible polyplexes by atomic force microscopy.Human-protein-derived peptides for intracellular delivery of biomolecules.Dynamics of nucleic acid/cationic polymer complexation and disassembly under biologically simulated conditions using in situ atomic force microscopy.A Simple, Highly Efficient Method for Heterologous Expression in Mammalian Primary Neurons Using Cationic Lipid-mediated mRNA Transfection.In vivo messenger RNA introduction into the central nervous system using polyplex nanomicelle.Binary gene induction and protein expression in individual cells.Cytoplasmic expression systems triggered by mRNA yield increased gene expression in post-mitotic neurons.Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition.Inhibition of Xenograft tumor growth by gold nanoparticle-DNA oligonucleotide conjugates-assisted delivery of BAX mRNAMultifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release.Self-assembled Messenger RNA Nanoparticles (mRNA-NPs) for Efficient Gene Expression.Breaking up the correlation between efficacy and toxicity for nonviral gene deliveryRNA transfer and its use in dendritic cell-based immunotherapy.Multifunctional triblock copolymers for intracellular messenger RNA deliveryBiomaterials for mRNA delivery.Stimulus-controlled delivery of drugs and genes.Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy.Polymeric nanoparticles for gene delivery.Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines.Melittin-grafted HPMA-oligolysine based copolymers for gene delivery.Polyplex gene delivery modulated by redox potential gradients.Overexpression of Bcl-2 as a proxy redox stimulus to enhance activity of non-viral redox-responsive delivery vectors.Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy.Developing mRNA-vaccine technologies.Journey to the Center of the Cell: Current Nanocarrier Design Strategies Targeting Biopharmaceuticals to the Cytoplasm and NucleusAugmentation of epithelial resistance to invading bacteria by using mRNA transfections.Bioreducible hyperbranched poly(amido amine)s for gene delivery.Quantitative comparison between poly(L-arginine) and poly(L-lysine) at each step of polyplex-based gene transfection using a microinjection techniqueDNA release dynamics from bioreducible poly(amido amine) polyplexes.Effect of innate glutathione levels on activity of redox-responsive gene delivery vectorsCharge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animalsRNA replicon delivery via lipid-complexed PRINT protein particles.Aerosolized Non-viral Nucleic Acid Delivery in the Vaginal Tract of Pigs.Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.Enhancing nucleic acid delivery by photochemical internalization.
P2860
Q24794521-5E66C1AA-3D3F-4DE2-AF52-70049B214FD0Q24814709-7E95612C-140E-4D28-BCA9-6A2D63CEEC15Q27011249-D220B4ED-B189-47F7-97A4-5865841809F9Q30486944-D137BEDF-29C0-46C6-A28C-E5C0FB5015B7Q30596693-FAF66DA8-C6E4-4AB4-B34A-8C8419255312Q33671439-AFFC1404-CA57-4ADE-B6D9-1917EE205364Q34093882-F6612F1B-8640-4051-A8C7-40C139B84A12Q34097275-38845F29-642D-4D30-A84D-070CCE6F099DQ34508332-E542551C-D3B2-4C8F-9F10-BB8A8F24EFF0Q34589906-C525000B-8828-4306-974A-4C200574F669Q34715976-6D0526AA-B138-4D23-9612-12F1A32D14F7Q34766975-12D2F05C-A8EB-45A3-B228-CA409588B0ECQ34999961-EEAE5457-7C7B-425F-868B-4DC02FFD7627Q35000872-DF70B80A-1054-42AA-A1B3-D660CC84D185Q35688089-5AEBF173-86BE-4287-92B0-B7E807B52C79Q35909697-919A3C8E-09B9-473B-B783-6AB8F0BA77DEQ35971611-C0B6056D-0159-4AA9-832B-63D56DBD2141Q36065947-741D7AA6-F7E9-4B2A-8430-CB0C237D5EF1Q36140780-0DA398CC-18B2-4AC6-91D8-395CB95C7847Q36271488-FEB6C5A8-EB9B-4BC8-AB2F-8168C02298EDQ36316864-AAD2BC94-0065-411D-9132-0201CD20C57BQ36417403-15ED1D30-59B9-44D1-BF3E-DCC42E6C0A1EQ36460846-23515BB8-2678-4B2F-87D5-866B4578B29EQ36512540-7AF9DA2C-106B-435C-B53D-BA355F286E41Q36553868-986C953F-7F9A-4120-BF8B-C7513C374FA4Q36627789-79D64F78-E8B5-4313-87CA-B1E9D5C5A446Q36669884-85B840DC-0BDA-43BD-B54D-346BE427D125Q36673747-6322D800-6E31-48AC-9869-59881BA22A6DQ36684597-A45E47A9-92A9-4373-B336-703689E32661Q36689670-25270F6D-E8E3-4190-A2DA-A1CE590F6241Q37264851-22D4EEFF-745D-470F-8EE7-EFEBBC029D3BQ37384338-06B1278F-3DE8-46DB-A7E0-26AA03C60B90Q37386284-F52A4FF7-712D-4B95-B441-220496302156Q37388713-48631FF7-4DE1-47A5-AA51-0005F6D75FC7Q37468294-82B968AE-03B0-4EAD-B074-5AE82E01F8FBQ37612455-F1532948-7B02-4DD2-9CE1-739DC286AFA9Q37628162-C732CCDF-64CD-4306-8C23-458553B0F83BQ37838639-E3180D68-C759-4041-9734-103ACFF095A3Q38028961-40475FF7-5AAA-4C0E-AA24-D3B756590EA3Q38136242-608DAC49-665D-4989-BD78-D489D5AD2088
P2860
Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Peptide-mediated RNA delivery: ...... rimary and post-mitotic cells.
@en
Peptide-mediated RNA delivery: ...... rimary and post-mitotic cells.
@nl
type
label
Peptide-mediated RNA delivery: ...... rimary and post-mitotic cells.
@en
Peptide-mediated RNA delivery: ...... rimary and post-mitotic cells.
@nl
prefLabel
Peptide-mediated RNA delivery: ...... rimary and post-mitotic cells.
@en
Peptide-mediated RNA delivery: ...... rimary and post-mitotic cells.
@nl
P2093
P2860
P356
P1476
Peptide-mediated RNA delivery: ...... rimary and post-mitotic cells.
@en
P2093
P2860
P304
P356
10.1093/NAR/29.18.3882
P407
P577
2001-09-01T00:00:00Z